In HR+, HER2- breast cancer, highly proliferative disease, as demonstrated by Ki-67 index ≥20% and several multi-gene assays, has also been shown to be associated with higher risk of disease recurrence [5, 8–12]. Here, ERBB2 is linked to breast cancer.